Design Strategies for and Stability of mRNA-Lipid Nanoparticle COVID-19 Vaccines.

Liu, Ting; Tian, Yang; Zheng, Aiping; Cui, Chunying

Liu, Ting; Tian, Yang; Zheng, Aiping; Cui, Chunying.

Afiliação

Liu T; Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.
Tian Y; State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing 100850, China.
Zheng A; State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Beijing 100850, China.
Cui C; Department of Pharmaceutics, School of Pharmaceutical Sciences, Capital Medical University, Beijing 100069, China.

Polymers (Basel) ; 14(19)2022 Oct 06.

Article em En | MEDLINE | ID: mdl-36236141

Palavras-chave

COVID-19; lipid nanoparticle; mRNA; preparation; quality control; stability

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Polymers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google